Disease severity in SIOD appears inversely proportionate to overall residual SMARCAL1 activity [15], although substantial phenotypic variation was noted among patients carrying the same mutation even within families [1,16]. The gene discussed is SMARCAL1; the disease is Schimke immuno-osseous dysplasia.